MIRNA is a collaborative research network working across nine countries in sub-Saharan Africa and South Asia to strengthen maternal immunisation programmes in readiness for the introduction of new life-saving vaccines which will improve foetal and infant health.
Maternal vaccines protect mothers and infants from life-threatening infectious diseases during the most vulnerable stages of life.
A cross-institutional, cross-country consortium representing key regions in Africa and Asia.
Learn about the work MIRNA and others have been doing to support implementation of maternal vaccines
Subscribe to MIRNA's newsletter and follow updates to stay informed about the latest research and activities.
Clinical trials are becoming increasingly digital, yet efforts to strengthen community engagement have not always kept pace with this shift. While technology is now commonly used for recruitment, data ...
Community engagement is widely recognised as an ethical and practical requirement in health research, yet there is limited clarity about how it is implemented in low- and middle-income countries. ...
The paper by Hickey et al. (2022) addresses a question many global health researchers face but often find it hard to answer clearly: what does “good” community and public ...
Geneva, 25 July 2025 – The Board of Gavi, the Vaccine Alliance this week endorsed a series of adjustments to bring Gavi’s strategy for its next five-year period (2026-2030) in line with available resources while it continues to engage with ... Read more
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more
